$1.35 -0.09 (%) Dendreon Corp - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD | Sep. 11, 2014 | 17:41PM EST
  2. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus | Aug. 15, 2014 | 12:18PM EST
  3. Morning Market Losers

    Benzinga | Aug. 12, 2014 | 09:51AM EST
  4. Dendreon's Debt Problem: Mulls Wiping Out Shareholders

    Benzinga | Aug. 12, 2014 | 09:19AM EST
  5. Morning Market Movers

    Benzinga | Jul. 8, 2014 | 09:37AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 8, 2014 | 08:04AM EST
  7. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 24, 2014 | 08:07AM EST
  8. Cantor Weighs In On Dendreon Leadership Change

    Benzinga | Jun. 10, 2014 | 10:50AM EST
  9. Morning Market Losers

    Benzinga | Jun. 10, 2014 | 09:43AM EST
  10. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View

    Benzinga | Apr. 15, 2014 | 10:27AM EST
  11. Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented at EAU Congress, Will Show Immune Responses with PROVENGE Enhanced, Sustained

    Benzinga | Apr. 11, 2014 | 07:02AM EST
  12. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga | Apr. 10, 2014 | 07:39AM EST
  13. Mid-Afternoon Market Update: Markets Rally on Easing Ukraine Tensions as Dendreon Pulls Back

    Benzinga | Mar. 4, 2014 | 15:44PM EST
  14. Morning Losers for Mar. 4, 2014: RSH, MDR, WBMD, CLF, DNDN

    Benzinga | Mar. 4, 2014 | 11:00AM EST
  15. Benzinga's Top Downgrades

    Benzinga | Mar. 4, 2014 | 08:44AM EST
  16. Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon Gains

    Benzinga | Mar. 3, 2014 | 12:39PM EST
  17. Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean Security Business For $1.93B

    Benzinga | Mar. 3, 2014 | 10:30AM EST
  18. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga | Mar. 3, 2014 | 10:27AM EST
  19. Morning Market Movers

    Benzinga | Mar. 3, 2014 | 10:10AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Mar. 3, 2014 | 08:07AM EST
  21. Earnings Scheduled For March 3, 2014

    Benzinga | Mar. 3, 2014 | 04:42AM EST
  22. Mid-Afternoon Market Update: Markets Recovering Towards the End of the Session as Dendreon Shares Inexplicably Fall

    Benzinga | Jan. 22, 2014 | 15:38PM EST
  23. Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

    Benzinga | Jan. 11, 2014 | 11:46AM EST
  24. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga | Nov. 12, 2013 | 16:41PM EST
  25. Earnings Expectations For The Week Of November 11: Walmart And Other Retailers

    Benzinga | Nov. 10, 2013 | 12:45PM EST
  26. UPDATE: Maxim Upgraded Dendreon, Raises High PT

    Benzinga | Oct. 28, 2013 | 10:22AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 28, 2013 | 08:14AM EST
  28. Benzinga's Weekend M&A Chatter

    Benzinga | Oct. 27, 2013 | 19:14PM EST
  29. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)

    Benzinga | Oct. 25, 2013 | 15:36PM EST
  30. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga | Oct. 11, 2013 | 14:33PM EST
  31. Dendreon Reports Presentation of PROVENGE® Data at '13 European Cancer Congress, Says Data Showed Robust Immune Response

    Benzinga | Sep. 27, 2013 | 07:32AM EST
  32. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga | Sep. 25, 2013 | 12:52PM EST
  33. Dendreon Reports Marketing Authorization for Provenge in EU

    Benzinga | Sep. 17, 2013 | 08:32AM EST
  34. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)

    Benzinga | Sep. 14, 2013 | 11:47AM EST
  35. RBC Sets Likelihoods For Dendreon Sale Possibilities Moving Forward, Cuts Target To $3

    Benzinga | Aug. 28, 2013 | 12:04PM EST
  36. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga | Aug. 27, 2013 | 13:29PM EST
  37. Stocks Hitting 52-Week Lows

    Benzinga | Aug. 26, 2013 | 10:21AM EST
  38. UPDATE: Deutsche Bank Downgrades Dendreon on Approaching Headwinds

    Benzinga | Aug. 23, 2013 | 11:02AM EST
  39. Stocks Hitting 52-Week Lows

    Benzinga | Aug. 23, 2013 | 09:56AM EST
  40. Benzinga's Top Pre-Market Losers

    Benzinga | Aug. 23, 2013 | 08:17AM EST
  41. Benzinga's Top Downgrades

    Benzinga | Aug. 23, 2013 | 07:39AM EST
  42. An Ocean of 52-Week Lows - 50% Off High, Second Quarter Financials

    GuruFocus | Aug. 11, 2013 | 11:34AM EST
  43. Mid-Afternoon Market Update: Markets All Red as Dendreon Continues to Fall

    Benzinga | Aug. 9, 2013 | 15:58PM EST
  44. Mid-Day Market Update: Markets Fall Sharply, Priceline Surges On Earnings Beat

    Benzinga | Aug. 9, 2013 | 12:27PM EST
  45. Mid-Morning Market Update: Markets Edge Lower, Lions Gate Reports Q1 Profit

    Benzinga | Aug. 9, 2013 | 10:40AM EST
  46. Benzinga's Top Pre-Market Losers

    Benzinga | Aug. 9, 2013 | 08:19AM EST
  47. Price Target on Dendreon Slashed from $1 to $0 at Wedbush, Says Expecting Restructuring of Convertible Debt

    Benzinga | Aug. 9, 2013 | 07:46AM EST
  48. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 8, 2013 | 08:18AM EST
  49. Mid-Afternoon Market Update: Dendreon Skyrockets as The Markets Trade in the Red

    Benzinga | Aug. 5, 2013 | 15:59PM EST
  50. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga | Jul. 26, 2013 | 10:46AM EST
Trading Center